A five-month-old baby with a spinal disorder has become the first NHS patient in England to be treated with a potentially life-saving drug that can prolong life.
The baby who's become the first patient in England to get a potentially life-saving drug with a £1.79 million a dose price tag on the NHS.
A low-cost, widely used anti-inflammatory drug improved survival in patients with Covid-19, the first treatment to show life-saving promise months into the pandemic.
Professor Peter Horby, Professor of Emerging Infectious Diseases and Global Health, has said that dexamethasone is the 'only drug shown to reduce mortality'.
Around 90% of experimental vaccines never reach the clinic because of problems in development or manufacture.